Skip to main content

and
  1. Article

    Open Access

    siRNA-E6 sensitizes HPV-16-related cervical cancer through Oxaliplatin: an in vitro study on anti-cancer combination therapy

    Persistent infection with high-risk Human papillomaviruses (HPV), such as hr-HPV-16 and hr-HPV-18, lead to cervical cancer, the fourth most common cancer in the world. In the present study, we investigated the...

    Parisa Shiri Aghbash, Nima Hemmat, Behzad Baradaran in European Journal of Medical Research (2023)